These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3326424)

  • 1. [Elimination of drugs by hemofiltration. Principles and literature data].
    Hilt H; Keller F
    Anasth Intensivther Notfallmed; 1987 Dec; 22(6):278-82. PubMed ID: 3326424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug dosing during continuous arteriovenous hemofiltration.
    Bickley SK
    Clin Pharm; 1988 Mar; 7(3):198-206. PubMed ID: 3281789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug administration in critically ill patients with acute renal failure.
    Kroh UF
    New Horiz; 1995 Nov; 3(4):748-59. PubMed ID: 8574606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations.
    Golper TA; Wedel SK; Kaplan AA; Saad AM; Donta ST; Paganini EP
    Int J Artif Organs; 1985 Nov; 8(6):307-12. PubMed ID: 4077288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
    Kroh U; Hofmann W; Dehne M; el Abed K; Lennartz H
    Anaesthesist; 1989 May; 38(5):225-32. PubMed ID: 2660626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro.
    Ittner KP; Roth G; Gruber M; Pawlik M; Taeger K
    J Antimicrob Chemother; 2005 Aug; 56(2):360-4. PubMed ID: 15983025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of therapeutic drugs by continuous arteriovenous hemofiltration.
    Golper TA; Pulliam J; Bennett WM
    Arch Intern Med; 1985 Sep; 145(9):1651-2. PubMed ID: 4026495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of cephalosporins by continuous arteriovenous ultrafiltration (CAVU) and hemofiltration (CAVH).
    Lau AH; Pyle K; Kronfol NO; Libertin CR
    Int J Artif Organs; 1989 Jun; 12(6):379-83. PubMed ID: 2777396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy in severe liver failure].
    Hruby K; Kleinberger G
    Leber Magen Darm; 1982 Oct; 12(5):188-92. PubMed ID: 7182698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma kinetics of small molecules during and after hemofiltration: decrease in hemofiltration efficiency related to increase in ultrafiltration rate.
    Haas T; Dongradi G; Villeboeuf F; de Viel E; Fournier JF; Duruy D
    Clin Nephrol; 1983 Apr; 19(4):193-200. PubMed ID: 6851256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotherapy in the aged].
    Huber W; Turnheim K
    Wien Klin Wochenschr; 1987 Mar; 99(6):173-80. PubMed ID: 3590798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage.
    Böhler J; Donauer J; Keller F
    Kidney Int Suppl; 1999 Nov; (72):S24-8. PubMed ID: 10560800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of convective dose in hemofiltration and hemodiafiltration: "predilution" vs. "postdilution" reinfusion.
    Colussi G; Frattini G
    Hemodial Int; 2007 Jan; 11(1):76-85. PubMed ID: 17257360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug clearance in patients undergoing continuous arteriovenous hemofiltration.
    Rubino M
    Clin Pharm; 1985; 4(6):620. PubMed ID: 4075732
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel model for prediction of human drug clearance by allometric scaling.
    Tang H; Mayersohn M
    Drug Metab Dispos; 2005 Sep; 33(9):1297-303. PubMed ID: 15958605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration.
    Joos B; Schmidli M; Keusch G
    Nephrol Dial Transplant; 1996 Aug; 11(8):1582-5. PubMed ID: 8856215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].
    Morabito S; Guzzo I; Vitaliano E; Muzi L; Solazzo A; Pistolesi V; Pierucci A
    G Ital Nefrol; 2006; 23 Suppl 36():S127-38. PubMed ID: 17068740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.